Shom Goel MD

Physician

450 Brookline AveYawkey 12, Dana-Farber Cancer InstituteBoston, MA 02215
Phone+1 617-335-3937

Dr. Goel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goel's full profile Already have an account?

Education & Training

The University of Adelaide Faculty of Health SciencesClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2018 - 2026

Clinical Trials

Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer Start of enrollment: 2017 May 26
TERMINATED
PHASE2

Publications & Presentations

PubMed

Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer.
Paolo Tarantino, Jaeyoon Cha, Busem Binboga Kurt, Xiangying Chu, Bojana Jovanović
NPJ Breast Cancer. 2026-02-13
5 citations
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer.
Shom Goel, Bojana Jovanović, Xiangying Chu, Melissa Hughes, Timothy K Erick
Clinical Cancer Research. 2025-04-14
Navigating life as an early career researcher.
Shruti Bhatt, Yash Chhabra, Merav Cohen, Anniina Färkkilä, Shom Goel
Trends in Cancer. 2025-04-01

Press Mentions

Experts to Explore Steps After CDK4/6 Inhibitors in HR-Positive, HER2-Negative Metastatic Breast CancerDecember 9th, 2025
Breast Cancer Updates from ESMO 2022September 21st, 2022
Studies Highlight ‘Potential New Targets for Immunotherapy’August 22nd, 2017